Search Tag: Navidea
2013 24 Apr
Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the...Read more
2013 16 Apr
Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary...Read more